Advanced Filters
noise
Found 64,783 clinical trials
W Weibing Miao, MD

68Ga-FAPI-Biotin PET/CT in Patients With Various Types of Cancer

As a new dual targeting PET radiotracer, 68Ga-FAPI-Biotin is promising as an excellent imaging agent applicable to various cancers. In this study, we observed the safety, biodistribution and radiation dosimetry of 68Ga-FAPI-Biotin in patients with various types of cancer and compared them with the results of 68Ga-FAPI or 18F-FDG imaging …

18 - 90 years of age All Phase N/A

Effect of an Exercise Program for Frail Older Adults

Despite the high level of evidence for physical activity as a countermeasure for frailty, the current Flemish standard of care does not include structural PA interventions for community-dwelling frail older adults. One barrier for this, is the high cost of supervised physical activity programmes. Therefore, in this pragmatic randomised controlled …

70 years of age All Phase N/A
L Lei Huang

A Phase 2 Study to Evaluate the Efficacy and Safety of ENN0403 in Subjects with DME

This is a multicenter, randomized, parallel study to evaluate the efficacy and safety of two doses of ENN0403 in subjects with diabetic macular edema (DME). Approximately 60 subjects will be randomized to receive ENN0403 capsule orally once a day at the low dose or high dose with a 1:1 ratio. …

18 - 80 years of age All Phase 2
H Huichao Zheng, MD

Single-port Versus Multi-port Robotic Surgery for Rectal Cancer

Single-port versus multi-port robotic surgery for rectal cancer

18 years of age All Phase N/A
Z Zeynep ARABACI

Evaluation of the Psychoeducation Program Given to the Elderly Living Alone at Home in Terms of Some Parameters

It was aimed to evaluate the effectiveness of the psychoeducation program given to the elderly living alone at home. In this context, the psychoeducation given was planned to evaluate the effect of the psychological well-being, self-integration and coping levels of the elderly.

65 - 95 years of age All Phase N/A
D Dwight H. Owen, MD, MS, FACP

Vismodegib and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer

This phase Ib trial tests the safety, side effects, and best dose of the combination of vismodegib and atezolizumab in treating patients with non-small cell lung cancer (NSCLC) that has come back after a period of improvement (recurrent) or has spread from where it first started (primary site) to other …

18 years of age All Phase 1
D David McCall

A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine in Pediatric Relapsed and Refractory Acute Leukemias

To find the highest safe dose of ziftomenib that can be combined with venetoclax and azacitidine in pediatric participants with acute leukemia that has certain types of genetic mutations (changes).

2 - 21 years of age All Phase 1
B Baozhong Li

Treating Nectin-4-positive Advanced Breast Cancer with XKDCT293 (Nectin-4-CAR-T)

A single-center, single-arm, dose-escalation exploratory clinical trial of the safety, efficacy, and pharmacokinetics of XKDCT 293 (Nectin-4-CAR-T) in Nectin-4-positive advanced breast cancer

18 - 75 years of age All Phase 1
Ü Ülkü yılmaz, PHD

The Effect of Elderly Care Training Given to Nursing Students on Ageism

geism is a multidimensional term that includes different attitudes, prejudices, behaviors and actions shown to a person simply because of his or her age. Today, in most societies in the world, elderly individuals are discriminated against. This discrimination stems from the negative attitudes of family members and society in general …

18 years of age All Phase N/A
C Chaelin Lee, BSPT

Feasibility and Safety of Digital Rehab Platform for Bedridden Patients

Study Title Rehabilitation Program for Bedridden Patients Using Digital Devices Study Purpose This study aims to evaluate the effectiveness of a rehabilitation program using digital devices and apps for bedridden patients in a hospital setting. The goal is to determine if digital rehabilitation can help improve physical function and contribute …

19 years of age All Phase N/A

Simplify language using AI